Marchesi, I.; Fais, M.; Fiorentino, F.P.; Bordoni, V.; Sanna, L.; Zoroddu, S.; Bagella, L.
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment. Int. J. Mol. Sci. 2022, 23, 3581.
https://doi.org/10.3390/ijms23073581
AMA Style
Marchesi I, Fais M, Fiorentino FP, Bordoni V, Sanna L, Zoroddu S, Bagella L.
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment. International Journal of Molecular Sciences. 2022; 23(7):3581.
https://doi.org/10.3390/ijms23073581
Chicago/Turabian Style
Marchesi, Irene, Milena Fais, Francesco Paolo Fiorentino, Valentina Bordoni, Luca Sanna, Stefano Zoroddu, and Luigi Bagella.
2022. "Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment" International Journal of Molecular Sciences 23, no. 7: 3581.
https://doi.org/10.3390/ijms23073581
APA Style
Marchesi, I., Fais, M., Fiorentino, F. P., Bordoni, V., Sanna, L., Zoroddu, S., & Bagella, L.
(2022). Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment. International Journal of Molecular Sciences, 23(7), 3581.
https://doi.org/10.3390/ijms23073581